MedTrace Logo

Body Mass Index (BMI) and Quality of Life (QoL) in Cancer Patients

NCT03873064 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1380

Last updated 2024-02-02

No results posted yet for this study

Summary

BMI is a simple and widely recorded variable that may capture obesity or cachexia in cancer patients. How BMI is associated to health-related quality of life (HR-QoL) in such patients is poorly investigated.

High BMI may be associated to obesity, an increased burden of comorbidity, reduced physical activity and, in some settings, to more aggressive oncological disease. On the other hand, low BMI may reflect enhanced weight loss, cachectic syndrome, higher tumor burden and adverse prognostic features which all deteriorate quality of life. The aim of the present study is to evaluate the association of BMI and HR-QoL as measured by the EORTC-QLQ-C30 questionnaire in several cancer settings (such as localized vs metastatic or distinct primary tumors).

Conditions

  • Neoplasm Malignant
  • Body Weight
  • Quality of Life

Sponsors & Collaborators

  • S.I.C.O.G. partners

    collaborator OTHER

  • University of Rome Tor Vergata

    lead OTHER

Principal Investigators

  • Mario Roselli · Tor Vergata University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-15
Primary Completion
2029-01-15
Completion
2034-01-15

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03873064 on ClinicalTrials.gov